Distribuzione geografica
Continente #
NA - Nord America 5691
EU - Europa 1103
AS - Asia 654
AF - Africa 7
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7458
Nazione #
US - Stati Uniti d'America 5689
CN - Cina 377
TR - Turchia 255
UA - Ucraina 243
IT - Italia 198
DE - Germania 172
PL - Polonia 158
SE - Svezia 120
GB - Regno Unito 110
FI - Finlandia 80
VN - Vietnam 11
BE - Belgio 6
SD - Sudan 6
FR - Francia 5
CZ - Repubblica Ceca 3
NL - Olanda 3
AU - Australia 2
CA - Canada 2
IN - India 2
JP - Giappone 2
BG - Bulgaria 1
CH - Svizzera 1
DK - Danimarca 1
ES - Italia 1
EU - Europa 1
HK - Hong Kong 1
IL - Israele 1
IR - Iran 1
KR - Corea 1
RO - Romania 1
SA - Arabia Saudita 1
SG - Singapore 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 7458
Città #
Fairfield 899
Woodbridge 794
Houston 593
Ann Arbor 434
Chandler 418
Jacksonville 403
Seattle 348
Ashburn 335
Cambridge 301
Wilmington 290
Izmir 171
Warsaw 158
Nanjing 108
Princeton 98
Milan 95
Boardman 75
San Diego 69
Beijing 66
Dearborn 45
Addison 41
Nanchang 41
Ferrara 40
Falls Church 38
Boydton 31
Shenyang 27
Hebei 26
Des Moines 23
Jiaxing 21
Mountain View 21
Redwood City 17
Changsha 15
Tianjin 14
Norwalk 13
Dong Ket 11
Kunming 11
London 11
Lanzhou 8
Jinan 7
Orange 7
Shanghai 6
Brussels 5
Changchun 5
Rome 5
Auburn Hills 4
Indiana 4
Los Angeles 4
San Francisco 4
Walnut 4
Detroit 3
Guangzhou 3
Khartoum 3
New York 3
Zhengzhou 3
Chengdu 2
Hefei 2
Lawrence 2
Philadelphia 2
Redmond 2
Shaoxing 2
Simi Valley 2
Toronto 2
Birmingham 1
Bologna 1
Capri 1
Caserta 1
Central 1
Centurion 1
Chicago 1
Den Haag 1
Dortmund 1
East Lansing 1
Ferrara di Monte Baldo 1
Florence 1
Fuzhou 1
Gent 1
Haifa 1
Haikou 1
Hangzhou 1
Hanover 1
Helsinki 1
Imola 1
Kish 1
Mainz 1
Melbourne 1
Messina 1
Nettuno 1
New Delhi 1
Paris 1
Perth 1
Phoenix 1
Prague 1
Providence 1
Pusan 1
San Mateo 1
Santa Clara 1
Scadicci 1
Serra 1
Singapore 1
Sofia 1
Stockholm 1
Totale 6234
Nome #
Phenotypic knockout of nerve growth factor in adult transgenic mice reveals severe deficits in basal forebrain cholinergic neurons, cell death in the spleen and skeletal muscle dystrophy 241
NGF steers microglia toward a neuroprotective phenotype 225
The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor 122
Amyloid plaque-independent deficit of early postnatal visual cortical plasticity in the 5xFAD transgenic model of Alzheimer's disease. 121
Characterization of melatonin receptors and signal transduction system in rat arteries forming the circle of Willis 114
Delivery of NGF to the brain: intranasal versus ocular administration in anti-NGF transgenic mice 111
Acute cholinergic rescue of synaptic plasticity in the neurodegenerating cortex of anti-nerve-growth-factor mice 106
Neutralization of Nerve Growth Factor impairs proliferation and differentiation of adult neural progenitors in the subventricular zone 106
On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer’s disease 105
Alzheimer-like neurodegeneration in aged antinerve Growth factor transgenic mice 104
Environmental enrichment delays the onset of memory deficits and reduces neuropathological hallmarks in a mouse model of Alzheimer-like neurodegeneration 104
Intranasal "painless" human nerve growth factors slows amyloid neurodegeneration and prevents memory deficits in app x PS1 mice 102
Identification of a caspase-derived N-terminal tau fragment in cellular and animal Alzheimer's disease models 102
Dark rearing blocks the developmental down-regulation of brain-derived neurotrophic factor messenger RNA expression in layers IV and V of the rat visual cortex 100
null 100
Pathogen-Free Husbandry Conditions Alleviate Behavioral Deficits and Neurodegeneration in AD10 Anti-NGF Mice. 99
Autoradiographic localization of putative melatonin receptors in the brains of two old world primates: Cercopithecus aethiops and Papio ursinus 99
Functional Characterization of Human ProNGF and NGF Mutants: Identification of NGF P61SR100E as a "Painless" Lead Investigational Candidate for Therapeutic Applications 99
A small molecule targeting the multifactorial nature of Alzheimer's disease 99
A dual mechanism linking NGF/ProNGF imbalance and early inflammation to Alzheimer's disease neurodegeneration in the AD11 anti-NGF mouse model 98
Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice 97
Gene expression biomarkers in the brain of a mouse model for Alzheimer's disease: Mining of microarray data by logic classification and feature selection 96
Taking pain out of NGF: a "painless" NGF mutant, linked to hereditary sensory autonomic neuropathy type V, with full neurotrophic activity 96
ProNGF drives localized and cell selective parvalbumin interneuron and perineuronal net depletion in the dentate gyrus of transgenic mice 96
Dissecting the role of sortilin receptor signaling in neurodegeneration induced by NGF deprivation 95
Rat visual cortical neurones express TrkA NGF receptor 94
Differential regulation of brain-derived neurotrophic factor messenger RNA cellular expression in the adult rat visual cortex 94
A carnivore species (Canis familiaris) expresses circadian melatonin rhythm in the peripheral blood and melatonin receptors in the brain 93
Early inflammation and immune response mRNAs in the brain of AD11 anti-NGF mice 93
ProNGF\NGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice 93
Localization and characterization of melatonin binding sites in the brain of the rabbit (Oryctolagus cuniculus) by autoradiography and in vitro ligand-receptor binding 93
Time window in cholinomimetic ability to rescue long-term potentiation in neurodegenerating anti-nerve growth factor mice 93
The positional identity of mouse ES cell-generated neurons is affected by BMP signaling 92
Intranasal delivery of therapeutic proteins for neurological diseases 91
Melatonin signal transduction and mechanism of action in the Central Nervous System. Using the rabbit cortex as a model 91
Transgenic mice with chronic NGF deprivation and Alzheimer's disease-like pathology display hippocampal region-specific impairments in short- and long-term plasticities 91
Peripheral Neutralization of Nerve Growth Factor Induces Immunosympathectomy and Central Neurodegeneration in Transgenic Mice 91
Development of a non invasive NGF-based therapy for Alzheimer's disease 90
Nerve growth factor regulates axial rotation during early stages of chick embryo development 90
Dissecting the involvement of tropomyosin-related kinase A and p75 neurotrophin receptor signaling in NGF deficit-induced neurodegeneration 90
SorLA Deficiency Dissects Amyloid Pathology from Tau and Cholinergic Neurodegeneration in a Mouse Model of Alzheimer's Disease 90
Postnatal development of GFAP in mouse visual cortex is not affected by light deprivation 89
Functional blockade of tyrosine kinase A in the rat basal forebrain by a novel antagonistic anti-receptor monoclonal antibody 89
null 89
Reduction of regional cerebral blood flow by melatonin in young rats 89
From genes to pain: nerve growth factor and hereditary sensory and autonomic neuropathy type V 89
Ganstigmine and donepezil improve neurodegeneration in AD11 antinerve growth factor transgenic mice 88
2-Bromomelatonin: synthesis and characterization of a potent melatonin agonist 88
Towards non invasive nerve growth factor therapies for Alzheimer's disease 87
In vitro receptor binding properties of a "painless" NGF mutein, linked to hereditary sensory autonomic neuropathy type V 85
Distribution and characterization of the melatonin receptors in the hypothalamus and pituitary gland of three domestic ungulates 83
Nerve growth factor scales endocannabinoid signaling by regulating monoacylglycerol lipase turnover in developing cholinergic neurons 83
Mismatch between BDNF mRNA and protein expression in the developing visual cortex: the role of visual experience 82
Pathogen Free Conditions Slow the Onset of Neurodegeneration in a Mouse Model of Nerve Growth Factor Deprivation 82
Non-human transgenic animals for the study of neurodegenerative syndromes 82
Endogenous A beta causes cell death via early tau hyperphosphorylation 81
Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice 81
Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons 81
Painless Nerve Growth Factor: A TrkA biased agonist mediating a broad neuroprotection via its actions on microglia cells 79
Muscular dystrophy in adult and aged anti-NGF transgenic mice resembles an inclusion body myopathy 77
The retina as a window to early dysfunctions of Alzheimer's disease following studies with a 5xFAD mouse model 77
In the adult hippocampus, chronic nerve growth factor deprivation shifts GABAergic signaling from the hyperpolarizing to the depolarizing direction 76
Effects of the cholinesterase inhibitor galantamine in a mouse model of Alzheimer's disease, the anti-nerve growth factor AD11 transgenic mice 72
Long-term memantine treatment prevents behavioral deficits in a mouse model of sporadic Alzheimer's disease 72
Failure of nicotine-dependent enhancement of synaptic efficacy at Schaffer-collateral CA1 synapses of AD11 anti-nerve growth factor transgenic mice 70
Beta-amyloid plaques in a model for sporadic Alzheimer's disease based on transgenic anti-nerve growth factor antibodies 69
Electrophysiological and behavioral effect of ozone on mice olfactory bulb 65
Memoquin: A new therapeutic poly-agent for Alzheimer's disease 63
Non-human transgenic animals for the study of neurodegenerative syndromes 63
Rescue of the neurodegenerative phenotype in AD11 anti-NGF mice. 62
Cholinergic striatal neurons are increased in HSAN V homozygous mice despite reduced NGF bioavailability 61
Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta-mediated cortical synaptic dysfunction 60
Abeta-dependent Inhibition of LTP in different intracortical circuits of the visual cortex: the role of RAGE 59
Nerve Growth Factor regulates astrocyte physiology in vivo 57
Interaction between NH2-tau fragment and Aß in AD mitochondria contributes to the synaptic deterioration 56
Antagonization of NGF in adult mice by transgenic antibodies causes progressive learning and memory impairments 56
null 54
Distribution and pharmacological characterization of melatonin receptors in the brain of the Japanese quail (Coturnix japonica) 51
Characterization of endothelin(A) receptors in cerebral and peripheral arteries of rat 49
Expression of the melatonin receptors in Xenopus laevis 49
Muteins of hNGF, therapeutic uses and pharmaceutical compositions 47
Vasoactive intestinal peptide-like immunoreactive fibers in the pineal gland of the sheep 45
The NGFR100W Mutation Specifically Impairs Nociception without Affecting Cognitive Performance in a Mouse Model of Hereditary Sensory and Autonomic Neuropathy Type V 44
null 41
Inhibitor of astrocyte TNF alpha for use in the treatment of neurological diseases 36
null 35
Intranasal delivery of BDNF rescues memory deficits in AD11 mice and reduces brain microgliosis 29
Involvement of Bradykinin Receptor 2 in Nerve Growth Factor Neuroprotective Activity 26
Nerve Growth Factor Neutralization Promotes Oligodendrogenesis by Increasing miR-219a-5p Levels 25
Graphene Promotes Axon Elongation through Local Stall of Nerve Growth Factor Signaling Endosomes 21
Alzheimer-like neurodegeneration in aged anti-nerve growth factor mice 17
Acute cholinergic rescue of synaptic plasticity in the neurodegenerating cortex of anti-nerve growth factor mice 16
Enteric Alpha-Synuclein Inclusions, Colonic Inflammation, Increased Mucosal Permeability and Alterations of Bowel Neuromuscular Functions Precede Central Neurodegeneration in a Transgenic Mouse Model of Parkinson's Disease 16
Taking pain out of NGF: a "painless" NGF mutant with full neurotrophic activity 13
Temporal progression of ALzheimer-like neurodegeneration in mice expressing anti-Nerve Growth Factor recombinant antibodies 12
Unraveling the Role of Dopaminergic and Calretinin Interneurons in the Olfactory Bulb 10
Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology 10
Getting Into the Brain: The Intranasal Approach to Enhance the Delivery of Nerve Growth Factor and Its Painless Derivative in Alzheimer’s Disease and Down Syndrome 10
Understanding pain perception through genetic painlessness diseases: The role of NGF and proNGF 8
Totale 7656
Categoria #
all - tutte 14748
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14748

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201822 0000 00 00 08410
2018/20191314 64714 1837 14123 91223302448
2019/20201998 33179122335 183236 207167 175755137
2020/20211227 1077448145 61113 29147 5120016191
2021/2022954 481198433 3940 6162 318184272
2022/2023963 1416012134 158124 12189 124000
Totale 7661